Earnings Call Summary | MINISO(MNSO.US) Q1 2024 Earnings Conference

The following is a summary of the MINISO Group Holding Limited (MNSO) Q1 2024 Earnings Call Transcript:Financial Performance:MINISO Group's Q1 2024 revenue increased by 26%, reaching RMB 3.72 billion

moomoo AIMay 14 20:20 ET · Conference Call

Mingchuang Premium's Q1 revenue reached a record high, and the speed of store expansion reached the fastest quarter｜Financial News

On the afternoon of May 14, Mingchuang Premium Group announced financial results for the first quarter of 2024. The data shows that this is the Q1 where Mingchuang Premium's revenue reached a record high and stores expanded the fastest. The company went overseas smoothly. Overseas market revenue increased 53% year over year, exceeding the company's most optimistic expectations and setting a new record for the first quarter. Among them, overseas direct management grew by more than 80% for four consecutive quarters. Furthermore, the TOP TOY brand has been profitable for two consecutive quarters. Financial data shows that in the first quarter, the company's total revenue increased 26% year on year to 3.72 billion yuan, up 26% year on year; gross profit margin was 43.4%, compared to last year

wallstreetcnMay 14 08:32 ET

Wanwuyun has launched an industry revolution

Revaluation.

wallstreetcnMay 11 21:00 ET

BeiGene Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 51.35% TD Cowen $236 → $254 Maintains Buy 04/24/2024 40.62% TD Cowen $235 → $236 Maintains Buy

BenzingaMay 9 12:14 ET

BeiGene Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results.

BeiGene Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results.

BenzingaMay 8 10:31 ET

BeiGene GAAP EPADS of -$2.41 Beats by $0.48, Revenue of $751.65M Beats by $76.42M

Seeking AlphaMay 8 06:16 ET

BeiGene Q1 2024 GAAP EPADS $(2.41) Beats $(2.89) Estimate, Sales $751.652M Beat $676.451M Estimate

BeiGene (NASDAQ:BGNE) reported quarterly losses of $(2.41) per share which beat the analyst consensus estimate of $(2.89) by 16.61 percent. This is a 27.84 percent increase over losses of $(3.34) per

BenzingaMay 8 06:10 ET

信義能源：2023年報

Futu NewsApr 30 06:00 ET · Announcements

名創優品：董事會會議日期

Futu NewsApr 30 04:45 ET · Announcements

泰格醫藥：2023年股東週年大會通告

Futu NewsApr 30 04:42 ET · Announcements

泰格醫藥：2023年度報告

Futu NewsApr 30 04:36 ET · Announcements

三生製藥：2023 年度報告

Futu NewsApr 30 04:30 ET · Announcements

綠葉製藥：年報 2023

Futu NewsApr 29 10:54 ET · Announcements

建業新生活：2023年度報告

Futu NewsApr 29 10:47 ET · Announcements

信達生物：2023年報

Futu NewsApr 29 10:36 ET · Announcements

融創服務：2023年度報告

Futu NewsApr 29 10:28 ET · Announcements

翰森製藥：2023年報

Futu NewsApr 29 09:43 ET · Announcements

巨子生物：二零二三年年報

Futu NewsApr 29 09:36 ET · Announcements

藥明康德：2024年第一季度報告

Futu NewsApr 29 09:03 ET · Announcements

啓明醫療-B：2023年度報告

Futu NewsApr 29 09:00 ET · Announcements